Maze Therapeutics, Inc. (MAZE) stock
MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$32.87−1.03 (-3.04%)
Close on Nov 17, 2026Market cap $1.83BP/E –Yield –
Maze Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Maze Therapeutics's price to book ratio was 4.5× on Nov 11, 2026, against 4.8× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.5× | −0.8 |
| 2025 | Dec 31, 2025 | 5.2× | – |
See a number that looks wrong?